News | January 12, 2015

Proton Therapy Center Czech Celebrates Two Years

European center has treated 750 patients from 22 countries

Proton Therapy Center Czech, PTC, two years, anniversary

Image courtesy of Proton Therapy Center Czech.

January 6, 2015 — For two years now, Proton Therapy Center Czech (PTC) in Prague has been among the world’s top proton therapy facilities. Having treated altogether 750 patients from 22 world countries, the center has gradually opened most of its treatment rooms and launched a two-shift operation in reaction to the growing demand for proton beam therapy.

The center hosted several professional visits in 2014. Dutch specialists came to Prague to join the Czech and Dutch roundtable organized under the auspices of the Embassy of the Kingdom of the Netherlands. They were particularly interested in the case of a steady patient growth and their indication. With a similar goal, the center hosted a visit of 25 Swedish physicians and physicists involved in preparation of a new proton facility in Uppsala, Sweden. A group of British physicists from the National Physics Laboratory were interested in absolute measurement of proton radiation dosimetry. Thus, Prague has the first center to offer a double-precision measurement of its proton beam; thereby offering patients an even higher level of safety and security during proton irradiation.

Today, the PTC accepts patients with:

  • CNS tumors
  • Head and neck tumors
  • Gastrointestinal tumors
  • Urological malignity
  • Retroperitoneal and abdominal sarcoma (besides GIST)
  • Tumors in children
  • Malignant lymphoma

 

Other indications to be treated soon are:

  • Lung cancer – non-small cell carcinoma
  • Eye melanoma

 

The most frequent patients at the PTC are men with prostate cancer. This corresponds to a United States study from April 2014. The study, presented at the annual conference of the National Association for Proton Therapy, confirmed 97 percent curability in men treated with early-stage prostate carcinoma. A sample of 4,000 patients who participated in the study underwent proton therapy five to 10 years ago. Most of them have not experienced a recurrence of their disease so far, do not suffer from impotency or incontinence, and 98 percent believe they made the best treatment decision for themselves.

Another group of tumors where proton therapy has benefitted and which are most frequently treated in PTC Czech are tumors of the brain and central nervous system, including meningeoma, glioma, chordoma, chondrosarcoma and neurinoma. There is a very good tolerance of proton beam therapy in case of this group of tumors. “Compared to conventional radiotherapy, proton therapy minimizes the dose to healthy tissue surrounding the tumor, thus decreasing the risk of unwanted side effects of treatment,” said Stepan Vinakurau, M.D.

One of the priorities of the Czech Proton Center is treatment of pediatric cancer patients. The children’s program of treatment and accompanying hospitalization and anesthesia was launched in April 2013. Today, PTC has treated 50 children from the Czech Republic and elsewhere. “The average patient is a child under 10 years old with a curable brain tumor or axial sarcoma,” explained Barbora Ondrová, M.D., a radiation oncologist responsible for the PTC’s pediatric treatment program. “Anesthesia was required for approximately 30 percent of them and 40 percent needed a combined treatment with concomitant chemotherapy.“

Not every patient has attracted as much attention as Ashya King, a British boy whose parents chose the Prague center for his treatment. Especially for children, the distance and admission time are an issue as there is a lack of specialized pediatric oncologists informed about all available treatment methods abroad.

Most countries do not have their own proton therapy centers. Thus, their representatives are looking for the treatment options abroad as well as seek help with installation of their own centers. This was also the reason for the visit of the Governor of Sichuan, a 90-million population Chinese province. Last but not least, an Agreement of cooperation was signed this year with Belarus, Bashkortostan and Kazakhstan. Their representatives are not only interested in treatment of their patients but also in training of their specialists and using of “know how” when building their centers.

The high level of expertise of the Czech specialists in proton therapy is confirmed by the fact that in 2016, PTC and Prague will host PTCOG 2016, an international congress in particle therapy. More than 1,000 world top oncologists, physicians and physicists specialised in proton and ion therapy are going to take part in this event.

For more information: www.proton-cancer-treatment.com

Related Content

Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
MedStar Georgetown Conducts World's First Hyperscan Proton Therapy Treatment
News | Proton Therapy | April 27, 2018
For the first time, cancer patients in the Washington, D.C. metropolitan region have access to proton therapy, now...
First Patient Treated on Mevion's S250i Proton Therapy System
News | Proton Therapy | April 05, 2018
Mevion Medical Systems announced the treatment of the first patient in the world on the Mevion S250i Proton Therapy...
MEDraysintell released a report in January revising its projection for the number of proton therapy centers worldwide by 2030 down from 1,200 to 900. The company said that more than 50 proton therapy treatment rooms would need to be opened every year from 2018 to 2030 to hit the original projection of 1,200.

MEDraysintell released a report in January revising its projection for the number of proton therapy centers worldwide by 2030 down from 1,200 to 900. The company said that more than 50 proton therapy treatment rooms would need to be opened every year from 2018 to 2030 to hit the original projection of 1,200.

Feature | Proton Therapy | March 06, 2018 | By Jeff Zagoudis
Proton therapy has experienced major growth in the last decade, but that growth seems to have slowed slightly in recent...
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
RayStation Selected for India’s First Proton Center
News | Proton Therapy | February 01, 2018
February 1, 2018 – Apollo Hospitals, Asia´s foremost integrated healthcare provider, has selected RayStation for a ne
IBA Announces First Patient Treated with Proteus PLUS in The Netherlands
News | Proton Therapy | January 25, 2018
January 25, 2018 –  IBA (Ion Beam Applications SA) has announced that the University Medical Center Groningen (UMCG)
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
Overlay Init